COST

943.02

-1.17%↓

69.01

+0.1%↑

163.8

+0.56%↑

PEP

139.45

-0.06%↓

KDP.US

33.33

+0.03%↑

COST

943.02

-1.17%↓

69.01

+0.1%↑

163.8

+0.56%↑

PEP

139.45

-0.06%↓

KDP.US

33.33

+0.03%↑

COST

943.02

-1.17%↓

69.01

+0.1%↑

163.8

+0.56%↑

PEP

139.45

-0.06%↓

KDP.US

33.33

+0.03%↑

COST

943.02

-1.17%↓

69.01

+0.1%↑

163.8

+0.56%↑

PEP

139.45

-0.06%↓

KDP.US

33.33

+0.03%↑

COST

943.02

-1.17%↓

69.01

+0.1%↑

163.8

+0.56%↑

PEP

139.45

-0.06%↓

KDP.US

33.33

+0.03%↑

Kodu・Aktsiate loetelu・European Wax Center Inc (Class A)

E
European Wax Center Inc (Class A)

Suletud

4.19 -2.1

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

4.15

Max

4.28

Põhinäitajad
By Trading Economics
Sissetulek	-503K 2.6M
Müük	1.7M 51M
P/E Sektori keskmine	24.15 27.757
Kasumimarginaal	4.997
Töötajad	124
EBITDA	1.7M 15M

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	+27.96% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	13. aug 2025

Turustatistika
By TradingEconomics
Turukapital	52M 267M
Eelmine avamishind	6.29
Eelmine sulgemishind	4.19

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

3.12 / N/A Toetus ja vastupanu

European Wax Center Inc (Class A) Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. aug 2025, 21:42 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4. aug 2025, 21:21 UTC

Tulu

Suurimad hinnamuutused turgudel

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4. aug 2025, 20:45 UTC

Tulu

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4. aug 2025, 19:15 UTC

Suurimad hinnamuutused turgudel

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4. aug 2025, 23:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4. aug 2025, 23:41 UTC

Market Talk

Nikkei May Rise on Fed Stimulus Hopes

4. aug 2025, 23:28 UTC

Market Talk

Global Equities Roundup: Market Talk

4. aug 2025, 23:28 UTC

Market Talk

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4. aug 2025, 21:30 UTC

Tulu

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4. aug 2025, 21:21 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4. aug 2025, 21:18 UTC

Tulu

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4. aug 2025, 20:25 UTC

Market Talk

India Hits Back Over Russian Oil Purchases -- Market Talk

4. aug 2025, 20:25 UTC

Tulu

Transocean 2Q Loss $938M >RIG

4. aug 2025, 20:25 UTC

Tulu

Transocean 2Q Loss/Shr $1.06 >RIG

4. aug 2025, 20:18 UTC

Tulu

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4. aug 2025, 20:15 UTC

Tulu

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4. aug 2025, 20:14 UTC

Tulu

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4. aug 2025, 20:14 UTC

Tulu

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4. aug 2025, 20:14 UTC

Tulu

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4. aug 2025, 20:13 UTC

Tulu

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4. aug 2025, 20:09 UTC

Tulu

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4. aug 2025, 20:06 UTC

Tulu

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4. aug 2025, 19:41 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

4. aug 2025, 19:28 UTC

Market Talk

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4. aug 2025, 19:07 UTC

Market Talk

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4. aug 2025, 18:27 UTC

Market Talk

Gold Climbs on Rate Cut Speculation -- Market Talk

Võrdlus sarnastega

Hinnamuutus

European Wax Center Inc (Class A) Prognoos

Hinnasiht

By TipRanks

27.96% tõus

12 kuu keskmine prognoos

Keskmine 5.4 USD 27.96%

Kõrge 6 USD

Madal 4 USD

Põhineb 6 Wall Streeti analüütiku instrumendi European Wax Center Inc (Class A) 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

6 ratings

Osta

Hoia

Müü

Põhineb 6 analüütiku instrumendi European Wax Center Inc (Class A) aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

3.12 / N/AToetus ja vastupanu

Recent bullish events outweigh bearish events.

There are no events.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest European Wax Center Inc (Class A)

European Wax Center, Inc. operates as the franchisor and operator of out-of-home waxing services in the United States. It offers body and facial waxing services; and pre- and post-service products, including ingrown hair serums, exfoliating gels, brow shapers, and skin treatments. The company was founded in 2004 and is headquartered in Plano, Texas.